Consent of Director Nominee
Pursuant to Rule 438 of Regulation C promulgated under the Securities Act of 1933, as amended (the Securities Act), in connection with the Registration Statement on Form S-1 (Registration No. 333-191879) (the Registration Statement) of Recro Pharma, Inc. (the Company), the undersigned hereby consents to being named and described as a director nominee in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.
IN WITNESS WHEREOF, the undersigned has executed this consent as of the 27th day of November, 2013.
|/s/ Michael Berelowitz|